Cardionyx is developing the first implantable, AI-driven neuromodulation system for heart failure. Unlike existing solutions, our device offers real-time, adaptive control of cardiovascular function without surgery, desensitization, or fixed settings. Positioned discreetly in the venous system, it adjusts to patient needs beat-by-beat, surpassing traditional baroreceptor and renal denervation therapies in safety, personalization, and long-term efficacy.